Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Nivashnee Naicker

Dados Biográficos

ID7730641
NOMENivashnee Naicker
PRENOMESNivashnee
SOBRENOMENaicker
ASSINATURANAICKER N
AFILIAÇÕESCentre for the AIDS Programme of Research in South Africa
ORCID0000-0002-8819-3825
VERIFICADOSim
TOTAL DE OBRAS3
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2015
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

  • Acceptability of Early Antiretroviral Therapy Among South African Women

    Open Access•Nigel Garrett, Emily Norman et al.•ARTICLE•AIDS and Behavior•2017

  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

Sem obras proeminentes nesta página.

  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

  • Acceptability of Early Antiretroviral Therapy Among South African Women

    Open Access•Nigel Garrett, Emily Norman et al.•ARTICLE•AIDS and Behavior•2017

  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

Immunology (3 obras) · Internal Medicine (3 obras) · Medicine (3 obras) · Cohort (2 obras) · Cohort study (2 obras) · Demography (2 obras) · Demography (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Human immunodeficiency virus (HIV (2 obras) · Public health (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae